From Luxury to Necessity: Lifestyle Drugs Market Set to Reach USD 175.72 Billion
Lifestyle Drugs Market to Reach USD 175.72 Billion by 2030, Fueled by Aesthetic Trends and Management of Modern "Urban Diseases" The global pharmaceutical landscape is witnessing a significant pivot as consumer focus shifts from purely curative treatments to "quality of life" enhancements. According to the latest strategic industry analysis by Maximize Market Research, the Lifestyle Drugs Market , which was valued at USD 108.71 Billion in 2023 , is projected to expand at a CAGR of 7.1% from 2024 to 2030 , ultimately reaching a market valuation of USD 175.72 Billion . Lifestyle drugs—medications used to treat non-life-threatening conditions often associated with lifestyle choices or the natural aging process—are no longer viewed as optional luxuries. Instead, they have become essential tools for modern consumers seeking to optimize their physical appearance, mental performance, and social well-being. Get the Edge: Download Your Exclusive Strategy Guide ...